| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.18 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |